Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseasesChangxiu Miao, Yujun Du, Lili Jiang et al.|Renal Failure|2022Cited by 55
Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)Keshu Zhou, Jianyong Li, Tingyu Wang et al.|Blood|2025Cited by 0